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Abstract Regulation of inositol phospholipid hydrolysis by
UTP and UDP in neuroblastomaUglioma hybrid cell line
NG108-15 was potentiated in the presence of ATP. The effect
of ATP was dose dependent and shifted the EC50 value for these
uracil nucleotides up to three powers of magnitude, having no
influence on the maximal value of the response. Adenine
nucleotides (ADP, AMP, adenosine 5P-O-(3-thiotriphosphate)
(ATPQS), L,Q-methyleneadenosine 5P-triphosphate (LQMeATP),
3P-O-(4-benzoyl)benzoyl ATP (BzATP) and 3P-deoxyadenosine
5P-O-(1-thio)triphosphate (dATPKS)) as well as adenosine, had
no influence on the pyrimidinoceptor response. The potentiation
effect was abolished by excess of EDTA. The results were in
agreement with the hypothesis of pyrimidinoceptor affinity
regulation via extracellular phosphorylation of the receptor
protein, initiated by ATP. This mechanism may have physio-
logical implication for functioning of uracil nucleotides as
endogenous signaling molecules.
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1. Introduction
Extracellular nucleotides regulate physiological responses in
various tissues by activating appropriate receptors [1]. Several
of these receptors possess clear selectivity against uracil nu-
cleotides, pointing to the possibility that these compounds
may function as endogenous signaling molecules [2^5]. The
pyrimidinoceptor concept can be supported by the possibil-
ities for recycling of the uracil nucleotides and formation of
their pools in cells [2]. However, the amount of the stored
UTP in granules of chroma⁄n cells and platelets forms only
about 10% of the appropriate ATP level [2]. Therefore the
question whether the uracil nucleotides can be released in
quantities su⁄cient to stimulate pyrimidinoceptors, has still
no answer.
Here we present evidence that the e¡ectiveness of UTP as
well as UDP to activate phosphoinositol lipid breakdown in
neuroblastomaUglioma hybrid cell line NG108-15 can be dra-
matically increased in the presence of ATP, probably initiat-
ing phosphorylation of the receptor by ectokinases. As the
shift of the e¡ective concentration interval for UTP and
UDP exceeded several powers of magnitude, far enough to
compensate for the low abundance of uracil nucleotides in
tissues, the e¡ect discovered may have a clear physiological
implication in cell regulation by these compounds.
2. Materials and methods
2.1. Cell culture
NeuroblastomaUglioma hybrid NG108-15 cells were obtained from
the European Collection of Cell Cultures and were grown in high-
glucose Dulbecco’s modi¢ed Eagle’s medium, supplemented with 10%
(v/v) of fetal calf serum, 0.1 mM hypoxanthine, 1 WM aminopterin,
and 16 WM thymidine. Cells were grown at 37‡C in a humidi¢ed
atmosphere of 95% air and 5% CO2 in 75-cm2 tissue culture dishes.
2.2. Chemicals
UTP, UDP, UMP, ATP, ADP, AMP, adenosine 5P-O-(3-thiotri-
phosphate) (ATPQS), L,Q-methyleneadenosine 5P-triphosphate
(LQMeATP), 3P-O-(4-benzoyl)benzoyl ATP (BzATP) and 3P-deoxyade-
nosine 5P-O-(1-thio)triphosphate (dATPKS) (Boehringer Mannheim,
Sigma, Amersham) were analyzed and puri¢ed by HPLC (Gilson)
on an anion exchange column Mono Q HR5/5 (Pharmacia Biotech)
by monitoring absorbance at 258 nm for adenine nucleotides and 270
nm for uracil nucleotides. Linear gradients from 0 to 0.8 M NaCl in
50 mM phosphate bu¡er (pH 7.0) and from 0.1 to 1.2 M ammonium
carbonate in water at the £ow rate 1 ml/min were used. The latter
gradient was used for preparative puri¢cation of nucleotides. Adeno-
sine and other chemicals were of the highest available grade of purity.
2.3. Assay of inositol phosphates
NG108-15 cells were seeded in a 24-well culture plate at density
V5U104 cells/well, and used for assay after 3 days when grown to
subcon£uence. Inositol lipids were radiolabeled by overnight incuba-
tion of cells with myo-[2-3H]inositol (2 WCi/ml, Amersham) in 200 Wl
of inositol-free DMEM. The medium was not changed after
[3H]inositol addition. Nucleotide e¡ects were initiated by addition of
50 Wl of ligand solution in 50 mM LiCl and the assay mixture was
incubated 10 min at 37‡C. The reaction was stopped by aspirating the
medium and adding 500 Wl of ice-cold 5% TCA. The TCA-containing
supernatant was extracted three times with 500 Wl of diethyl ether and
inositol phosphates were isolated by using Dowex AG1-X8 gel (Bio-
Rad, 100^200 mesh, formate form). The columns (bed volume 0.8 ml)
were washed with water (2U5 ml) and 50 mM ammonium formate
(10 ml) and inositol phosphates were eluted with 1 M ammonium
formate in 0.1 mM formic acid (2U5 ml). The amount of [3H]inositol
phosphates formed was determined by counting radioactivity of the
eluate (scintillation cocktail EcoLume, ICN). Under the experimental
conditions used the basal radioactivity of samples remained between
800 and 1000 cpm/sample and the maximal radioactivity achieved was
6000^7000 cpm/sample. The results were calculated as means þ S.E.M.
from three independent experiments and normalized versus the results
of the control experiments at 10 WM UTP concentration. The dose-
response curves were processed by a non-linear regression analysis
program Prism (Version 2.00).
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3. Results
3.1. Activation of phospholipase C by nucleotides in NG108-15
cells
The synthesis of inositol phosphates in NG108-15 cells was
activated by UTP and UDP in a dose-dependent manner,
yielding the EC50 values (3.9 þ 0.6)U1037 M and (1.3 þ
0.6)U1036 M, respectively (Fig. 1). The potency of UMP
was considerably weaker (EC50 = (7.5 þ 0.6)U1034 M). The
same biochemical response was also activated at high concen-
trations of ATP, ADP, ATPQS and dATPKS, characterized by
the EC50 values (3.0 þ 0.7)U1034 M, (2.4 þ 0.7)U1034 M,
(7.0 þ 0.8)U1034 M and (4.4 þ 0.9)U1034 M, respectively. In
the presence of LQMeATP, AMP and adenosine, there was no
statistically signi¢cant increase in formation of inositol phos-
phates if compared with the basal level. Thus, the receptors
revealed clear speci¢city for UTP and UDP.
At nucleotide concentrations above 1 mM a decrease of the
ligand-induced e¡ect was observed in the case of UTP and
UDP, as well as in the case of adenine nucleotides, resulting in
a bell-shaped form of the dose-response curves (data not
shown). However, as not relevant to the present study, these
e¡ects of high ligand concentration will be discussed else-
where.
3.2. In£uence of ATP on UTP and UDP induced synthesis
of inositol phosphates
Simultaneous application of ATP and UTP or ATP and
UDP led to a non-additive e¡ect, i.e. the total amount of
inositol phosphates formed did not exceed the level observed
at optimal concentration of UTP alone (Fig. 2). At the same
time the dose-response curves for UTP and UDP, measured in
the presence of ATP, revealed a signi¢cant potentiation of the
e¡ect of the uracil nucleotides. This shift of the dose-response
curves was clearly dependent on ATP concentration and in
the presence of 1 mM ATP the e¡ective UTP and UDP con-
centrations were lowered into the picomolar range, yielding
the EC50 values (1.1 þ 0.2)U10312 M and (1.2 þ 0.2)U10311
M, respectively (Fig. 2).
3.3. In£uence of other nucleotides on UTP induced synthesis
of inositol phosphates
The experiments described above were repeated in the pres-
ence of ADP, AMP and adenosine (10 WM^1 mM), as well as
LQMeATP and ATPQS (0.1 mM). It was found that none of
these ligands potentiated the UTP e¡ect on synthesis of ino-
sitol phosphates. Moreover, these ligands had no in£uence on
the maximal level of the UTP response.
3.4. E¡ect of EDTA on UTP induced synthesis of inositol
phosphates
In separate experiments 4 mM EDTA was added into the
assay medium before nucleotides to bind the divalent cations
present. It was found that the excess of this chelating ligand
had no e¡ect on the EC50 value for UTP, equal to
(2.0 þ 0.5)U1037 M in the Mg2 and Ca2 free medium, as
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Fig. 1. Dose-dependent stimulation of synthesis of inositol phos-
phates in neuroblastomaUglioma hybrid NG108-15 cells by uracil
and adenine nucleotides (a, UTP; E, UDP; O, UMP; b, ATP; F,
ADP; S, ATPQS; 8, dATPKS).
Fig. 2. Potentiation of the e¡ect of UTP (left) and UDP (right) on pyrimidinoceptor regulated synthesis of inositol phosphates in the presence
of various concentrations of ATP (O, 1 WM; E, 10 WM; 7, 100 WM; P, 1 mM). The dose-response curves for UTP (a), UDP (E) and ATP
(b) alone were shown for comparison.
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well as on the range of the response of cells observed. At the
same time the potentiating e¡ect of ATP on the UTP induced
inositol phosphate formation was completely abolished in the
presence of EDTA.
4. Discussion
Synthesis of inositol phosphates in NG108-15 cells was
regulated by nucleotide receptors, which revealed clear pref-
erence for UTP and UDP over ATP and its analogs. This
result agreed well with the rank order of the e¡ect of uracil
and adenine nucleotides, published by Lin for the same cell
line [6]. Therefore the uracil nucleotides may well act as en-
dogenous signaling molecules for these cells and the appropri-
ate receptors may belong to the P2Y4 and/or P2Y6 subtypes
[7^9].
Although the cell responses were evoked by UTP and ATP
at very di¡erent concentrations, Lin has suggested that both
these nucleotides interact with the same receptor on NG108-
15 cells [6]. This suggestion was based on the absence of
additivity between the e¡ects of UTP and ATP, as well as
on the possibility of desensitization of the cells to the e¡ects
of both these nucleotides by their extended pretreatment with
UTP. Although the same phenomena were observed in the
present study, a more signi¢cant di¡erence between the be-
havior of uracil and adenine nucleotides pointed to the in-
volvement of distinct regulatory mechanisms for uracil and
adenine nucleotides.
Firstly, in the presence of ATP a dramatic dose-dependent
increase in potency of uracil nucleotides was observed, while
no increase in potency of ATP analogs was found under the
same conditions. This means that most probably the uracil
and adenine nucleotides act at distinct target sites.
Secondly, among all the investigated adenine nucleotides
only ATP was able to enhance potency of UTP (and UDP),
although the synthesis of inositol phosphates was similarly
initiated by several adenine-containing ligands. Thus, the ac-
tivation of phospholipase C and potentiation of the e¡ect of
uracil nucleotides should occur via di¡erent mechanisms.
Although the former phenomenon may be related to some
still unspeci¢ed in£uence of the externally applied adenine
nucleotides on synthesis of inositol phosphates, the ligand
speci¢city of this e¡ect seems to support the idea of involve-
ment of some receptors. These receptors may well belong to
the channel-coupled subtypes, also governed by ATP and its
analogs. For example, the P2X7 receptor subtype, activated
by micromolar ATP concentrations and operating a non-se-
lective ion channel was found in this cell line [10]. Therefore,
it can be supposed that ATP may cause ‘leaking’ of intra-
cellular compounds, including uracil nucleotides, into the ex-
tracellular medium. Although the amount of uracil nucleoti-
des released through these ‘pores’ should be small, this may
still be su⁄cient to activate the pyrimidinoceptors, simultane-
ously potentiated by ATP. Following this hypothetical scheme
the non-additive nature of the maximal response of UTP and
ATP, as well as the desensitization phenomena observed by
Lin [6], can be easily understood.
The results of the present study point to the possibility that
the observed potentiation of pyrimidinoceptors on NG108-15
cells, occurring in the presence of ATP, can be related to
extracellular phosphorylation of these proteins. As the Q-phos-
phate of ATP is transferred to the target protein in this re-
action, the ATP analogs cannot participate in this process and
therefore were unable to potentiate pyrimidinoceptors. More-
over, as the actual substrate for protein kinases is MgATP,
the abolishment of the potentiation e¡ect in the presence of
EDTA also agrees with the phosphorylation hypothesis.
If the intracellular reversible phosphorylation of proteins
has been recognized as a key regulatory mechanism in numer-
ous cellular functions, much less is known about the regula-
tory role of the extracellular protein phosphorylation [11]. The
results of the present study point to the possibility that the
latter process may be implied in regulation of the responsive-
ness of NG108-15 cells to extracellular UTP. Until recently
the possibilities of cell regulation by uracil nucleotides have
been thought to be limited by low physiological concentration
of these compounds, not corresponding to the experimentally
detectable e¡ectiveness of binding of these ligands on the ap-
propriate receptors. Therefore the possibility of signi¢cant
increase in a⁄nity of pyrimidinoceptors through extracellular
phosphorylation of these proteins may have a clear physio-
logical signi¢cance for intracellular communication by means
of uracil nucleotides.
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